Business

June 4, 2014 9:35 PM

Cayce company out to transform SC pharmaceuticals

Nephron Pharmaceuticals Corp. officially opened for business Wednesday, marking two years of preparations including a $313 million investment that banks on a track record of successfully bringing new products to market.

Related content

Comments